Scheltens P - Search Results

1

Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease.

Bertens D, Knol DL, Scheltens P, Visser PJ; Alzheimer's Disease Neuroimaging Initiative. Bertens D, et al. Among authors: scheltens p. Alzheimers Dement. 2015 May;11(5):511-22. doi: 10.1016/j.jalz.2014.05.1754. Epub 2014 Aug 20. Alzheimers Dement. 2015. PMID: 25150730 Free PMC article.

2

Head trauma and Alzheimer's disease.

Nandoe RD, Scheltens P, Eikelenboom P. Nandoe RD, et al. Among authors: scheltens p. J Alzheimers Dis. 2002 Aug;4(4):303-8. doi: 10.3233/jad-2002-4405. J Alzheimers Dis. 2002. PMID: 12446932

3

Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study.

van Straaten EC, Scheltens P, Knol DL, van Buchem MA, van Dijk EJ, Hofman PA, Karas G, Kjartansson O, de Leeuw FE, Prins ND, Schmidt R, Visser MC, Weinstein HC, Barkhof F. van Straaten EC, et al. Among authors: scheltens p. Stroke. 2003 Aug;34(8):1907-12. doi: 10.1161/01.STR.0000083050.44441.10. Epub 2003 Jul 10. Stroke. 2003. PMID: 12855825

4

Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.

Korf ES, Wahlund LO, Visser PJ, Scheltens P. Korf ES, et al. Among authors: scheltens p. Neurology. 2004 Jul 13;63(1):94-100. doi: 10.1212/01.wnl.0000133114.92694.93. Neurology. 2004. PMID: 15249617

5

Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.

Schoonenboom NS, Mulder C, Vanderstichele H, Van Elk EJ, Kok A, Van Kamp GJ, Scheltens P, Blankenstein MA. Schoonenboom NS, et al. Among authors: scheltens p. Clin Chem. 2005 Jan;51(1):189-95. doi: 10.1373/clinchem.2004.039735. Epub 2004 Nov 11. Clin Chem. 2005. PMID: 15539465

6

Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study.

Goekoop R, Rombouts SA, Jonker C, Hibbel A, Knol DL, Truyen L, Barkhof F, Scheltens P. Goekoop R, et al. Among authors: scheltens p. Neuroimage. 2004 Dec;23(4):1450-9. doi: 10.1016/j.neuroimage.2004.08.006. Neuroimage. 2004. PMID: 15589109 Clinical Trial.

7

Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients.

Visser PJ, Scheltens P, Pelgrim E, Verhey FR; Dutch ENA-NL-01 Study Group. Visser PJ, et al. Among authors: scheltens p. Dement Geriatr Cogn Disord. 2005;19(2-3):126-33. doi: 10.1159/000082883. Epub 2004 Dec 23. Dement Geriatr Cogn Disord. 2005. PMID: 15627759

8

Peripheral electrical stimulation in Alzheimer's disease.

van Dijk KR, Scheltens P, Luijpen MW, Sergeant JA, Scherder EJ. van Dijk KR, et al. Among authors: scheltens p. Dement Geriatr Cogn Disord. 2005;19(5-6):361-8. doi: 10.1159/000084706. Epub 2005 Mar 30. Dement Geriatr Cogn Disord. 2005. PMID: 15802911 Free article. Clinical Trial.

9

Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study.

Rombouts SA, Barkhof F, Goekoop R, Stam CJ, Scheltens P. Rombouts SA, et al. Among authors: scheltens p. Hum Brain Mapp. 2005 Dec;26(4):231-9. doi: 10.1002/hbm.20160. Hum Brain Mapp. 2005. PMID: 15954139 Free PMC article.

10

Functional connectivity in elderly controls and AD patients using resting state fMRI: a pilot study.

Rombouts S, Scheltens P. Rombouts S, et al. Among authors: scheltens p. Curr Alzheimer Res. 2005 Apr;2(2):115-6. doi: 10.2174/1567205053585783. Curr Alzheimer Res. 2005. PMID: 15974906 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,252 results

Search Page